Akorn Recalls Erythromycin Pledgets Due to Microbial Contamination
Akorn, Inc. is recalling Erythromycin Pledgets USP, 2%, 60-count jars because the active pharmaceutical ingredient failed USP microbial tests.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a 'Severe' rating under the rubric, particularly given the risk of microbial contamination in a pharmaceutical product.
Plain-English summary
Akorn, Inc. is recalling Erythromycin Pledgets USP, 2%, 60-count jars, which are prescription-only products. The recall was initiated because the active pharmaceutical ingredient (API) failed USP microbial tests, indicating microbial contamination of the non-sterile product.
The affected product is manufactured by Ei LLC in Kannapolis, NC, and marketed by VersaPharm Incorporated in Marietta, GA. The specific NDC number is 61748-202-60. A total of 23,449 jars are involved in this recall, which has a nationwide distribution pattern.
The affected lots include Lot # 1446800 (Exp. 03/15), Lot # 1538100 (Exp. 05/15), Lot # 1538101 (Exp. 05/15), Lot # 1538200 (Exp. 06/15), and Lot # 1608200 (Exp. 08/15). Consumers and healthcare providers should check their inventory for these specific lot numbers and expiration dates. If the product matches the recalled description, it should be returned to the pharmacy or supplier for a refund or replacement, or disposed of according to local regulations.
The recalled product
- Product
- Erythromycin Pledgets USP, 2%, 60-count jar,Rx only, Manufactured by Ei LLC, Kannapolis, NC 28083, Marketed by VersaPharm Incorporated, Marietta, GA 30062, NDC 61748-202-60 .
- Manufacturer
- Akorn, Inc.
- Category
- Drug — Antibiotic
- Hazard
- Affected units
- 23,449
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot # 1446800
- Exp. 03/15 Lot # 1538100
- Exp. 05/15 Lot # 1538101
- Exp. 05/15 Lot # 1538200
- Exp. 06/15 Lot # 1608200
- Exp. 08/15
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Akorn, Inc.
See all →- HighGuaifenesin Oral Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighAkorn Hydromorphone Hydrochloride Injection Recalled Due to CGMP Deviations
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Calcitriol Injection Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-06-07
- HighTobramycin Ophthalmic Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighMidazolam Injection Recalled Due to Manufacturing Compliance and Stability Study Issues
FDA (Drugs) · 2023-06-07
Same hazard · microbial contamination
See all →- CriticalVictory Medical Center Pharmacy Recalls Glutathione Vials Due to Contamination
FDA (Drugs) · 2026-08-19
- HighMedline Medical Convenience Kits Recalled Due to Potential Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighMedline Convenience Kits Recalled Over Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15